RECOVERY - ACTNOW Clinical Trials Support under the Cancer Trails Support Unit

This action modifies an existing contract which provides clinicians across the United States and Canada access to cancer treatment trials. The goals are to provide a wide choice of clinical trial options to the largest possible number of investigators; involve a larger number of treating institutions in the clinical trials process; increase enrollment to cancer clinical trials; and streamline or eliminate redundant processes and procedures. Rationale for using other than fixed price: The primary purpose of the contract is to support the development of cancer clinical treatment trials sponsored by CTEP, NCI. The number of patients enrolled in each clinical trial is estimated at the start of the trial, but may fluctuate during the course of the study. In addition, the complexity of the protocols varies due to the phase, disease to be studied, drug(s) to be used and the statistical design of the trial. The uncertainties involved with enrolling human participants and the complexities of protocol development make it difficult to predict the amount of services required to support the clinical trials. Uncertainties involved in contract performance do not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost reimbursement type action is appropriate. DUNS 04950810